BRAF and thyroid cancer, nonmedullary, 2: The global analysis of genomic variants, gene and microRNA (miRNA) expression, aberrant methylation, and proteomic profiles revealed that mutations in BRAF and RAS, together with RET-PTC fusions, are the most common genetic alterations in both FTC and PTC.